Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Salmonella Paratyphi A O-antigen is the dominant, serovar-specific polysaccharide component of the bacterium’s outer membrane lipopolysaccharide (LPS)[2][5]. It is composed of a repeating tetrasaccharide unit with a backbone of rhamnose, mannose, galactose, and a branch of paratose, linked through the core oligosaccharide to lipid A. O-acetylation of rhamnose and glucosylation of galactose are structural modifications that contribute to its immunogenic and antigenic properties[2][6]. This antigen plays a critical role in Salmonella’s evasion of host immunity—modulating phagocytosis, resistance to serum killing, and triggering protective immune responses[5]. The O-antigen is a main target for candidate paratyphoid vaccines and acts as a key biomarker for serological detection and monitoring. Variability in its structure can affect vaccine coverage and efficacy, highlighting the need for precise antigen characterization in vaccine development[4][6][7]. Synthetic oligosaccharide derivatives and O-antigen-conjugated vaccines utilizing this structure have shown promising immunogenicity and protective efficacy in preclinical models[6].
Induction of protective antibody responses (vaccines employing Paratyphi A O-antigen elicit IgG that promotes opsonization and clearance by host immunity) Antibody-mediated neutralization and complement activation against Salmonella Paratyphi A Used as immunogenic antigen in conjugate vaccine design
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salmonella Paratyphi A O-antigen.